MethodsJournal of Pharmacology and PharmacotherapeuticsVol. 2 | Issue 4 | 2011 | pp. 295–299Open access
Starting a pharmacovigilance center: Actions for implementation
- 1*,
- 1
- 1 Department of Pharmacology, Veer Chandra Singh Garhwali Govt. Medical Science and Research Institute, Srinagar - 246 174, Garhwal, Uttarakhand, India Methods.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Mrinmoy Chakrabarty
Department of Pharmacology, Veer Chandra Singh Garhwali Govt. Medical Science and Research Institute, Srinagar - 246 174, Garhwal, Uttarakhand, India Methods.
Copyright: © 2011 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2011
How to cite
Chakrabarty, M., & Thawani, V. (2011). Starting a pharmacovigilance center: Actions for implementation. Journal of Pharmacology and Pharmacotherapeutics, 2(4), 295–299. https://doi.org/10.4103/0976-500X.85945
Abstract
With burgeoning reports of adverse drug reactions due to pharmacotherapy, pharmacovigilance (PV) is the buzz word in health care circles. While there are experts in this rapidly expanding fi eld, there are many health care professionals who do not fully appreciate the import of PV in the context of modern therapeutics. In view of the national directive to institutionalize a PV center in every medical college of India, there is an urgent need to inform, educate, and enlighten the readers about the constitution and dynamics of a PV center, which this article attempts to fulfi ll.
Keywords
Subject
Article metadata
| Title | Starting a pharmacovigilance center: Actions for implementation |
|---|---|
| Authors | Mrinmoy Chakrabarty; Vijay Thawani |
| Affiliations | Department of Pharmacology, Veer Chandra Singh Garhwali Govt. Medical Science and Research Institute, Srinagar - 246 174, Garhwal, Uttarakhand, India Methods. |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 2, Issue 4 (2011) |
Also in this issue
- ACE inhibitor and angiotensin-receptor blocker – A deadly combinationpp. 311–312
- The National Formulary of India 2010: Thorough and extensive revision of the preprint version neededpp. 219–20
- Research publications: Should they be mandatory for promotions of medical teachers?pp. 221–222
- The curious case of zinc for diarrhea: Unavailable, unprescribed, and unusedpp. 225–226
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellituspp. 230–235
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026